PPMI News

The Parkinson's Progression Markers Initiative is our landmark study launched in 2010 to deepen knowledge of Parkinson's and to better understand its onset and progression to speed the development of new treatments. Learn the latest news from the study here.

Could an Antioxidant Protect LRRK2 Carriers from Parkinson's?

March 11, 2019

A new study suggests urate may protect the genetic mutation that increases PD risk.

Learn more
PPMI Dispatch: The Study Enters a New Phase

December 19, 2018

The study completed enrollment and met the ambitious goal of enrolling 1,400 participants, including 600 with rare genetic mutations.

Learn more
The Michael J. Fox Foundation Joins BRAIN Commons to Accelerate Brain Disease Research

November 5, 2018

MJFF joins BRAIN Commons, a data sharing platform for data analyzes in PD, to help fuel collaborative science.

Learn more
The Appendix and Parkinson's: 'It's a Piece to the Puzzle'

November 2, 2018

Rachel Dolhun, MD, vice president of medical communication at the Foundation comments on these findings.

Learn more
Parkinson's Research: PPMI Clinical Study

Learn more
Parkinson's Progression Markers Initiative

Learn more
PPMI: The Benefits of Collaboration & Digital Health

September 13, 2018

Deputy CEO, Sohini Chowdhury, talked to Roche for an article discussing PPMI and the importance of sharing data.

Learn more